SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
How Should We Deal with Patient Heterogeneity in Economic Evaluation: A Systematic Review of National Pharmacoeconomic Guidelines
16 references·0 citing·45 second hop
How Should We Deal with Patient Heterogeneity in Economic Evaluation: A Systematic Review of National Pharmacoeconomic Guidelines (2013)How Should We Deal with Patient Heterogen…Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 (2012)Model Parameter Estimation an…What Do International Pharmacoeconomic Guidelines Say about Economic Data Transferability? (2010)What Do International Pharmac…Spanish recommendations on economic evaluation of health technologies (2010)Spanish recommendations on ec…Dangerous omissions: the consequences of ignoring decision uncertainty (2010)Dangerous omissions: the cons…Subgroups and Heterogeneity in Cost-Effectiveness Analysis (2008)Subgroups and Heterogeneity i…Value of Information on Preference Heterogeneity and Individualized Care (2007)Value of Information on Prefe…Decision Modelling For Health Economic Evaluation (2006)Decision Modelling For Health…A taxonomy of model structures for economic evaluation of health technologies (2006)A taxonomy of model structure…Review of guidelines for good practice in decision-analytic modelling in health technology assessment (2004)Review of guidelines for good…Generalisability in economic evaluation studies in healthcare: a review and case studies (2004)Generalisability in economic …Discrete choice experiments in health economics (2004)Discrete choice experiments i…Stratified cost‐effectiveness analysis: a framework for establishing efficient limited use criteria (2003)Stratified cost‐effectiveness…Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data (2003)Regression methods for covari…Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis (2002)Something old, something new,…Guidelines for Economic Evaluations in Italy: Recommendations from The Italian Group of Pharmacoeconomic Studies (2001)Guidelines for Economic Evalu…The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)The irrelevance of inference:…Cost-Effectiveness in Health and Medicine (1996)Methods for Meta-Analysis in Medical Research (2000)Methods for the Economic Evaluation of Health Care Programmes (2005)Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias (2009)Reporting of Patient-Reported Outcomes in Randomized Trials (2013)The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought (2016)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Methods for the economic evaluation of health care programmes (1987)Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies (2002)Simulation Modeling and Analysis. (1983)Discrete-Event System Simulation (1984)Simulation modeling and analysis (1999)Discrete event simulation for performance modelling in health care: a review of the literature (2010)Modeling Good Research Practices—Overview (2012)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Alternative to Mental Hospital Treatment (1980)Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R) (1987)An evaluation of bivariate random‐effects meta‐analysis for the joint synthesis of two correlated outcomes (2006)Statistical Analysis of Cost‐effectiveness Data (2006)Non‐parametric methods for cost‐effectiveness analysis: the central limit theorem and the bootstrap compared (2009)Net Health Benefits (1998)Statistical assessment of the learning curves of health technologies (2001)Use of Indirect and Mixed Treatment Comparisons for Technology Assessment (2008)Uncertainty and Patient Heterogeneity in Medical Decision Models (2010)The economic value of personalized medicine tests: what we know and what we need to know (2013)Decision Analysis: Introductory Lectures on Choices Under Uncertainty. (1969)Regret Theory: An Alternative Theory of Rational Choice Under Uncertainty (1982)Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. (2008)Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1 (2011)Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)Network meta‐analysis for indirect treatment comparisons (2002)Uncertain Judgements: Eliciting Experts' Probabilities (2006)Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7 (2012)State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3 (2012)Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force (2013)Empirical Evidence of Bias (1995)Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs (2000)Evaluating non-randomised intervention studies (2003)Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment (2006)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report (2016)Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report (2017)Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare (2018)Evidence Synthesis for Decision Making 2 (2012)Model Parameter Estimation and Uncertainty Analysis (2012)
this work references cited by second hop

References

  • 2006Decision Modelling For Health Economic Evaluation3,146 cited
  • 1999The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies891 cited
  • 2012Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6716 cited
  • 2004Review of guidelines for good practice in decision-analytic modelling in health technology assessment697 cited
  • 2006A taxonomy of model structures for economic evaluation of health technologies555 cited
  • 2002Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost‐effectiveness analysis535 cited
  • 2004Generalisability in economic evaluation studies in healthcare: a review and case studies441 cited
  • 2003Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data363 cited
  • 2010Spanish recommendations on economic evaluation of health technologies240 cited
  • 2008Subgroups and Heterogeneity in Cost-Effectiveness Analysis168 cited
  • 2007Value of Information on Preference Heterogeneity and Individualized Care151 cited
  • 2001Guidelines for Economic Evaluations in Italy: Recommendations from The Italian Group of Pharmacoeconomic Studies126 cited
  • 2010Dangerous omissions: the consequences of ignoring decision uncertainty112 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2004Discrete choice experiments in health economics108 cited
  • 2003Stratified cost‐effectiveness analysis: a framework for establishing efficient limited use criteria102 cited
  • 2010What Do International Pharmacoeconomic Guidelines Say about Economic Data Transferability?101 cited
  • Cited by

    No citing works inside the corpus for this window.